Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | -0.69% | -11.59% | -58.33% |
Chart calendar Altamira Therapeutics
Upcoming events on Altamira Therapeutics
Past events on Altamira Therapeutics
2024-04-10 08:30 | Q4 2023 Earnings Call |
2024-04-10 08:00 | Q4 2023 Earnings Release |
2024-01-22 | MRNA Based Therapeutics Summit |
2023-12-11 08:30 | Business Update Call |
2023-09-12 08:00 | Q2 2023 Earnings Call |
2023-09-12 07:30 | Q2 2023 Earnings Release |
2023-09-11 07:00 | H.C. Wainwright Global Investment Conference |
2023-03-20 | RNAi Based Therapeutics Summit |
2023-02-25 10:45 | American Academy of Allergy, Asthma & Immunology Meeting |
2023-02-17 07:30 | Extraordinary Shareholders Meeting |
2023-02-07 | RNA Therapeutics Conference |
2023-01-23 | mRNA-Based Therapeutics Summit Europe Conference |
2022-11-30 08:47 | Interim 2022 Earnings Release |
2022-11-15 | TIDES Europe Event |
2022-10-17 | RNA Leaders USA Congress |
2022-09-25 | RAS-Targeted Drug Development Summit |
2022-09-14 10:30 | Business Update Call |
2022-05-24 07:00 | H.C. Wainwright Global Life Sciences Investment Conference |
2022-04-12 08:00 | FY 2021 Earnings Call |
2022-04-12 07:30 | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 |
EBITDA Million CHF | Released Forecast Spread | -7,23 -11,0 33.99% | 0,00 | 0,00 |
EBIT Million CHF | Released Forecast Spread | -7,26 -10,6 31.76% | 0,00 | -7,85 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -6,83 -10,7 36.24% | 0,00 | 0,00 |
Net income Million CHF | Released Forecast Spread | -6,63 -9,31 28.74% | -3,87 | 0,00 |
EPS CHF | Released Forecast Spread | -912 -1 338 31.84% | -7,88 | 0,00 |
Announcement Date | 16/04/20 | 10/04/24 | - |
Quarterly results
Fiscal Period | Dezember | 2019 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million CHF | Released Forecast Spread | -3,15 -5,23 39.68% | ||||
Net income Million CHF | Released Forecast Spread | -3,03 -4,83 37.25% | ||||
EPS CHF | Released Forecast Spread | -248 -588 57.82% | ||||
Announcement Date | 16/04/20 | - | - | - | - |
Today 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 09:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-25 01:00 | ARGENX SE: Q2 2024 Earnings Release |
2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Altamira Therapeutics
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYTO Stock
- CYTO Stock
- Calendar Altamira Therapeutics